Source: European Journal of Pharmacology,. Unidade: FM
Subjects: COLITE ULCERATIVA, RECEPTORES, CITOCINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MABLEY, Jon et al. The adenosine A3 receptor agonist, N6-(3-iodobenzyl)-adenosine-5'-N-methyluronamide, is protective in two murine models of colitis. European Journal of Pharmacology, v. 466, p. 323-329, 2003Tradução . . Disponível em: https://doi.org/10.1016/s0014-2999(03)01570-x. Acesso em: 29 maio 2024.APA
Mabley, J., Soriano, F., Pacher, P., Haskó, G., Marton, A., Wallace, R., et al. (2003). The adenosine A3 receptor agonist, N6-(3-iodobenzyl)-adenosine-5'-N-methyluronamide, is protective in two murine models of colitis. European Journal of Pharmacology,, 466, 323-329. doi:10.1016/s0014-2999(03)01570-xNLM
Mabley J, Soriano F, Pacher P, Haskó G, Marton A, Wallace R, Salzman A, Szabó C. The adenosine A3 receptor agonist, N6-(3-iodobenzyl)-adenosine-5'-N-methyluronamide, is protective in two murine models of colitis [Internet]. European Journal of Pharmacology,. 2003 ; 466 323-329.[citado 2024 maio 29 ] Available from: https://doi.org/10.1016/s0014-2999(03)01570-xVancouver
Mabley J, Soriano F, Pacher P, Haskó G, Marton A, Wallace R, Salzman A, Szabó C. The adenosine A3 receptor agonist, N6-(3-iodobenzyl)-adenosine-5'-N-methyluronamide, is protective in two murine models of colitis [Internet]. European Journal of Pharmacology,. 2003 ; 466 323-329.[citado 2024 maio 29 ] Available from: https://doi.org/10.1016/s0014-2999(03)01570-x
